ImmuCell Corporation Cost of Goods Sold (Deprecated 2018-01-31)
ImmuCell Corporation (ICCC) reported Cost of Goods Sold (Deprecated 2018-01-31) of $1.52 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-05-14
- ImmuCell Corporation cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $1.52M, a 9.30% increase year-over-year.
- ImmuCell Corporation cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $1.92M, a 92.97% increase year-over-year.
- ImmuCell Corporation cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.07M, a 40.03% increase year-over-year.
- ImmuCell Corporation cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $828.25K, a 27.08% decline year-over-year.
- ImmuCell Corporation cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $5.21M, a 26.35% increase from fiscal 2016.
- ImmuCell Corporation cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $4.12M, a 3.66% increase from fiscal 2015.
- ImmuCell Corporation cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $3.98M, a 26.37% increase from fiscal 2014.
- ImmuCell Corporation cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $3.15M, a 6.83% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $1.52M 10-Q · filed 2018-05-14 | $3.44M derived: sum of 2 quarters · filed 2018-05-14 | $4.51M derived: sum of 3 quarters · filed 2018-05-14 | $5.34M derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $2.99M derived: sum of 2 quarters · filed 2018-03-29 | $3.82M derived: sum of 3 quarters · filed 2018-03-29 | $5.21M 10-K · filed 2018-03-29 |
| 2017-09-30 | $1.07M 10-Q · filed 2017-11-13 | $1.90M derived: sum of 2 quarters · filed 2017-11-13 | $3.29M 10-Q · filed 2017-11-13 | $4.28M derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-06-30 | $828.25K 10-Q · filed 2017-08-14 | $2.22M 10-Q · filed 2017-08-14 | $3.22M derived: sum of 3 quarters · filed 2018-05-14 | $3.98M derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-03-31 | $1.39M 10-Q · filed 2018-05-14 | $2.39M derived: sum of 2 quarters · filed 2018-05-14 | $3.15M derived: sum of 3 quarters · filed 2018-05-14 | $4.29M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $995.17K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $1.76M derived: sum of 2 quarters · filed 2018-03-29 | $2.89M derived: sum of 3 quarters · filed 2018-03-29 | $4.12M 10-K · filed 2018-03-29 |
| 2016-09-30 | $763.50K 10-Q · filed 2017-11-13 | $1.90M derived: sum of 2 quarters · filed 2017-11-13 | $3.13M 10-Q · filed 2017-11-13 | $4.17M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $1.14M 10-Q · filed 2017-08-14 | $2.36M 10-Q · filed 2017-08-14 | $3.40M derived: sum of 3 quarters · filed 2017-08-14 | $4.26M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $1.23M 10-Q · filed 2017-05-11 | $2.27M derived: sum of 2 quarters · filed 2017-05-11 | $3.13M derived: sum of 3 quarters · filed 2017-05-11 | $3.96M derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $1.90M derived: sum of 2 quarters · filed 2017-03-30 | $2.73M derived: sum of 3 quarters · filed 2017-03-30 | $3.98M 10-K · filed 2017-03-30 |
| 2015-09-30 | $860.53K 10-Q · filed 2016-11-10 | $1.69M derived: sum of 2 quarters · filed 2016-11-10 | $2.94M 10-Q · filed 2016-11-10 | $3.80M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $829.79K 10-Q · filed 2016-08-11 | $2.08M 10-Q · filed 2016-08-11 | $2.94M derived: sum of 3 quarters · filed 2016-08-11 | $3.64M derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $1.25M 10-Q · filed 2016-05-11 | $2.11M derived: sum of 2 quarters · filed 2016-05-11 | $2.81M derived: sum of 3 quarters · filed 2016-05-11 | $3.47M derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | $862.55K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $1.55M derived: sum of 2 quarters · filed 2016-03-25 | $2.22M derived: sum of 3 quarters · filed 2016-03-25 | $3.15M 10-K · filed 2016-03-25 |
| 2014-09-30 | $692.23K 10-Q · filed 2015-11-12 | $1.35M derived: sum of 2 quarters · filed 2015-11-12 | $2.29M 10-Q · filed 2015-11-12 | $3.24M derived: sum of 4 quarters · filed 2016-03-25 |
| 2014-06-30 | $661.20K 10-Q · filed 2015-08-13 | $1.59M 10-Q · filed 2015-08-13 | $2.54M derived: sum of 3 quarters · filed 2016-03-25 | $3.16M derived: sum of 4 quarters · filed 2016-03-25 |
| 2014-03-31 | $931.86K 10-Q · filed 2015-05-12 | $1.88M derived: sum of 2 quarters · filed 2016-03-25 | $2.50M derived: sum of 3 quarters · filed 2016-03-25 | $3.09M derived: sum of 4 quarters · filed 2016-03-25 |
| 2013-12-31 | $951.60K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $1.57M derived: sum of 2 quarters · filed 2016-03-25 | $2.15M derived: sum of 3 quarters · filed 2016-03-25 | $2.95M 10-K · filed 2016-03-25 |
| 2013-09-30 | $618.98K 10-Q · filed 2014-11-12 | $1.20M derived: sum of 2 quarters · filed 2014-11-12 | $1.99M 10-Q · filed 2014-11-12 | $2.67M derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-06-30 | $582.82K 10-Q · filed 2014-08-13 | $1.38M 10-Q · filed 2014-08-13 | $2.05M derived: sum of 3 quarters · filed 2015-03-26 | $2.50M derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-03-31 | $793.17K 10-Q · filed 2014-05-14 | $1.46M derived: sum of 2 quarters · filed 2015-03-26 | $1.92M derived: sum of 3 quarters · filed 2015-03-26 | $2.42M derived: sum of 4 quarters · filed 2015-03-26 |
| 2012-12-31 | $670.74K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $1.13M derived: sum of 2 quarters · filed 2015-03-26 | $1.63M derived: sum of 3 quarters · filed 2015-03-26 | $2.34M 10-K · filed 2015-03-26 |
| 2012-09-30 | $455.79K 10-Q · filed 2013-11-13 | $960.40K derived: sum of 2 quarters · filed 2013-11-13 | $1.66M 10-Q · filed 2013-11-13 | $2.24M derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-06-30 | $504.61K 10-Q · filed 2013-08-13 | $1.21M 10-Q · filed 2013-08-13 | $1.79M derived: sum of 3 quarters · filed 2014-03-26 | $2.27M derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-03-31 | $704.54K 10-Q · filed 2013-05-14 | $1.28M derived: sum of 2 quarters · filed 2014-03-26 | $1.76M derived: sum of 3 quarters · filed 2014-03-26 | $2.31M derived: sum of 4 quarters · filed 2014-03-26 |
| 2011-12-31 | $579.54K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $1.06M derived: sum of 2 quarters · filed 2014-03-26 | $1.61M derived: sum of 3 quarters · filed 2014-03-26 | $2.30M 10-K · filed 2014-03-26 |
| 2011-09-30 | $477.42K 10-Q · filed 2012-11-13 | $1.03M derived: sum of 2 quarters · filed 2012-11-13 | $1.72M 10-Q · filed 2012-11-13 | $2.25M derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-06-30 | $552.92K 10-Q/A · filed 2012-09-07 | $1.24M 10-Q/A · filed 2012-09-07 | $1.78M derived: sum of 3 quarters · filed 2013-03-28 | $2.29M derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-03-31 | $687.47K 10-Q · filed 2012-05-14 | $1.22M derived: sum of 2 quarters · filed 2013-03-28 | $1.74M derived: sum of 3 quarters · filed 2013-03-28 | $2.20M derived: sum of 4 quarters · filed 2013-03-28 |
| 2010-12-31 | $535.62K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $1.05M derived: sum of 2 quarters · filed 2013-03-28 | $1.51M derived: sum of 3 quarters · filed 2013-03-28 | $2.08M 10-K · filed 2013-03-28 |
| 2010-09-30 | $516.45K 10-Q · filed 2011-11-14 | $975.51K derived: sum of 2 quarters · filed 2011-11-14 | $1.55M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $459.06K 10-Q · filed 2011-08-15 | $1.03M 10-Q · filed 2011-08-15 | ||
| 2009-12-31 | $2.11M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |